Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.07B P/E - EPS this Y -9.80% Ern Qtrly Grth -
Income -1.28B Forward P/E 9.66 EPS next Y 6.80% 50D Avg Chg -
Sales 2.6B PEG 7.15 EPS past 5Y 11.23% 200D Avg Chg -4.00%
Dividend N/A Price/Book 1.09 EPS next 5Y 1.30% 52W High Chg -40.00%
Recommedations 2.10 Quick Ratio 0.78 Shares Outstanding 724.14M 52W Low Chg 25.00%
Insider Own 15.53% ROA 1.32% Shares Float 412.98M Beta 1.17
Inst Own 88.92% ROE -19.31% Shares Shorted/Prior 31.44M/29.37M Price 8.98
Gross Margin 66.04% Profit Margin -46.53% Avg. Volume 4,943,898 Target Price 7.61
Oper. Margin 10.76% Earnings Date Nov 5 Volume 5,750,901 Change -3.23%
About Clarivate Plc

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Clarivate Plc News
11/21/24 BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
11/19/24 Clarivate Reveals Highly Cited Researchers 2024 List
11/18/24 New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
11/13/24 Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
11/12/24 Clarivate Third Quarter 2024 Earnings: Misses Expectations
11/12/24 Clarivate Publishes 2023 Sustainability Report
11/10/24 Should You Think About Buying Clarivate Plc (NYSE:CLVT) Now?
11/07/24 Clarivate Launches New Sustainability Research Solution
11/06/24 Clarivate Reports Third Quarter 2024 Results
10/30/24 Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10/20/24 Shareholders in Clarivate (NYSE:CLVT) are in the red if they invested three years ago
10/16/24 Clarivate to Report Third Quarter 2024 Results on November 6, 2024
10/15/24 Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program
10/04/24 Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda
09/25/24 Clarivate Unveils Comprehensive Framework to Evaluate the Societal Impact of Research
09/24/24 New Clarivate Report Reveals Challenges and Trends Shaping IP Operations
09:42 AM Loss-Making Clarivate Plc (NYSE:CLVT) Expected To Breakeven In The Medium-Term
02:00 AM Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process
09/19/24 Clarivate Reveals Citation Laureates 2024
09/18/24 Clarivate Announces 15th Annual Pharmavision India Conference Agenda
CLVT Chatroom

User Image Stocksrunner Posted - 4 days ago

stocks bouncing back! $BGS is climbing from its $6.21 support, now at $6.36 with rsi rising to 30.28. $CLVT surges 5.41% to $4.87, edging closer to $4.57 support. $DEO, steady at $119.20, shows an oversold rsi of 30.40, hinting at potential. $EWCZ rockets 7.27% to $5.90 with $5.50 as key support, while $HALO jumps 5.26%, now at $44.81. timing’s key—watch for stronger breakouts past resistance for those golden entries!

User Image TheLearnerEarner Posted - 1 week ago

$CLVT ✅ UNDERVALUED stock swing trade - industrials - large cap - 5/9 F-Score - 1.17x relative volume - 1x analyst outperform rating - 3x analysts buy rating - earnings are forecast to grow approx. 97% per year - trading at approx. 33% below estimate of its fair value - short to medium term gains 📈 RSI: 21.15 (oversold) 📊 Analysts Price Target: $6.36 - $10.50 (41% - 133% above Price) 🌟 Range (12m) $4.43 - $9.61 💰 NEWSDESK (article idea is for CLVT only) 📰 https://finance.yahoo.com/news/think-buying-clarivate-plc-nyse-140920680.html

User Image circo_orsi Posted - 1 week ago

$CLVT time to load on . Just see how bearish articles are written to hammer it down . I am loading it .. catch when fear overcomes the mortals

User Image Bazzzigar Posted - 2 weeks ago

$CLVT added

User Image Bazzzigar Posted - 2 weeks ago

$CLVT

User Image tradingtwenty Posted - 2 weeks ago

Top 5 oversold stocks that have trended in the past 24 hours: $PACS 12.73🔥 $EL 14.82 $TRMD 15.14 $CLVT 18.13 $AVNM 19.02 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image Bazzzigar Posted - 2 weeks ago

$CLVT

User Image jParkz Posted - 2 weeks ago

$CLVT News Article Clarivate Launches New Sustainability Research Solution https://marketwirenews.com/news-releases/clarivate-launches-new-sustainability-research-solut-5659660779294726.html $CLVT

User Image Bazzzigar Posted - 2 weeks ago

$CLVT Let's Gooooo

User Image swingingtech Posted - 2 weeks ago

$CLVT https://wallstreetwaves.com/market-watch-clarivate-clvt-hits-oversold-territory-according-to-rsi/

User Image HaltTradeAlert Posted - 2 weeks ago

$CLVT Halt Time: 10:11:48 Issue Symbol: CLVT Reason Code: M Last Price: $5.23 Volume: 5.2 M Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

User Image _www_larval_com_ Posted - 2 weeks ago

$CLVT has reverted 6% higher to -20% (~3Mv) in the last few minutes, 11/15 options, follow for more volatility.

User Image HaltTradeAlert Posted - 2 weeks ago

$CLVT Halt Time: 09:54:26 Issue Symbol: CLVT Reason Code: M Last Price: $4.94 Volume: 2.5 M Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

User Image GetVector Posted - 2 weeks ago

Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $CLVT, $EXAS, $PACS, $RVLV.

User Image OpenOutcrier Posted - 2 weeks ago

$CLVT (-15.4% pre) Clarivate Reports Third Quarter 2024 Results https://ooc.bz/l/47067

User Image briefingcom Posted - 2 weeks ago

$CLVT: Clarivate reports EPS in-line, misses on revs; removes outlook for 2024 https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241106060817CLVT&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image DonCorleone77 Posted - 2 weeks ago

$CLVT Clarivate removes FY24 guidance amid CEO transition The company said, "As a result of the recent CEO transition and the work being done under the Value Creation Plan, the Company has removed its forward-looking outlook for 2024. All previous outlooks provided by the Company should no longer be relied upon."

User Image DonCorleone77 Posted - 2 weeks ago

$CLVT Clarivate reports Q3 adjusted EPS 19c, consensus 19c Reports Q3 revenue $622.2M, consensus $640.85M. "Clarivate's third quarter results are unsatisfactory and reflect an overdependency on fluctuating transactional revenue and areas of the business with low margin characteristics," said Matti Shem Tov, CEO. "As we look ahead, it is clear the Company has work to do to improve performance. Our Value Creation Plan is designed to increase subscription and re-occurring revenue, improve sales execution, accelerate innovation and continue portfolio solutions rationalization. We will leverage Clarivate's strong foundation, unique product offerings and talented team to take the necessary actions to improve predictability and drive profitable growth. Alongside the management team and Board, I am invigorated by the opportunities before us and remain focused on successfully executing our strategy to realize Clarivate's potential."

User Image Estimize Posted - 10/28/24

Wall St is expecting -1.04% YoY revenue growth for $CLVT in Q3, up from -2.77% in Q2 [Reporting 11/06 BMO] http://www.estimize.com/intro/cl

User Image WeeklyTrader Posted - 1 month ago

Prepare for potential downturns! $CLVT 7.5p RSI: 47.79% 50-day MA: $6.65 200-day MA: $6.95

User Image WeeklyTrader Posted - 1 month ago

Watch out for a dip! Consider a PUT on $CLVT at strike 7.5p. RSI: 54.39% 50-day MA: $6.52 200-day MA: $7.02

User Image WizzBlizz Posted - 09/29/24

$CLVT I recommend this as a long term buy.

User Image Stock_Titan Posted - 2 months ago

$CLVT Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process https://www.stocktitan.net/news/CLVT/clarivate-and-relatable-healthcare-forge-strategic-partnership-to-xd4bblj25eby.html

User Image smartkarma Posted - 2 months ago

$CLVT | Clarivate Plc: Initiation Of Coverage - Does It Have A Sustainable Competitive Advantage? - Major Drivers "Clarivate recently conducted its Q2 2024 Earnings Conference Call, marked by significant leadership changes and a detailed overview of strategic..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/clarivate-plc-initiation-of-coverage-does-it-have-a-sustainable-competitive-advantage-major-drivers

User Image Stock_Titan Posted - 2 months ago

$CLVT Clarivate Launches Generative AI-Powered Primo Research Assistant https://www.stocktitan.net/news/CLVT/clarivate-launches-generative-ai-powered-primo-research-u78okjvwlpuz.html

User Image hermitkatt Posted - 2 months ago

$CLVT load it here!

User Image Stocktwits Posted - 2 months ago

🚨 Today's Most Bullish Symbols 1. $NNBR 2. $CLVT 3. $DWSN 4. $CDRE 5. $CHD

User Image Stock_Titan Posted - 2 months ago

$CLVT Clarivate Launches Generative AI-Powered Web of Science Research Assistant https://www.stocktitan.net/news/CLVT/clarivate-launches-generative-ai-powered-web-of-science-research-3et3o7gfen0k.html

User Image Stock_Titan Posted - 3 months ago

$CLVT Clarivate Names Melanie Margolin as Chief Administrative and Legal Officer https://www.stocktitan.net/news/CLVT/clarivate-names-melanie-margolin-as-chief-administrative-and-legal-edvcdyugl6qz.html

User Image kinderspiel Posted - 3 months ago

$MLCO volume 3.3 m $CLVT volume 2.5 m $NVST volume 2.1 m $SATS volume 2.0 m $ETSY volume 1.9 m

Analyst Ratings
Barclays Underweight Aug 7, 24
RBC Capital Sector Perform Aug 7, 24
Goldman Sachs Buy May 9, 24
Morgan Stanley Equal-Weight Feb 28, 24
Barclays Underweight Feb 28, 24
RBC Capital Sector Perform Feb 28, 24
Oppenheimer Outperform Feb 28, 24
Oppenheimer Outperform Jan 8, 24
Wells Fargo Underweight Dec 15, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Samson James Gordon Chief Product Office.. Chief Product Officer May 16 Sell 14.2494 50,000 712,470 838,787 05/17/22
Samson James Gordon Chief Product Office.. Chief Product Officer May 11 Sell 13.91 58,000 806,780 888,787 05/13/22
Samson James Gordon Chief Product Office.. Chief Product Officer Mar 14 Sell 14.13 16,000 226,080 946,787 03/16/22